ACE2 function in the pancreatic islet: Implications for relationship between SARS-CoV-2 and diabetes

Area of Science:

• Endocrinology
• Virology
• Molecular Biology

Background:

• A link between SARS-CoV-2 infection and diabetes is proposed, but the molecular mechanisms are unclear.
• Angiotensin-converting enzyme 2 (ACE2) facilitates viral entry and plays a role in glucose homeostasis and insulin secretion.
• ACE2 expression in pancreatic islets, particularly beta cells, is debated but crucial for understanding diabetes pathogenesis.

Purpose of the Study:

• To elucidate the function of ACE2 in pancreatic beta cells.
• To investigate the potential role of ACE2 in SARS-CoV-2 entry into the pancreas.
• To explore the link between ACE2, SARS-CoV-2 infection, and diabetes development.

Main Methods:

• Review of existing literature on ACE2 function and SARS-CoV-2 interaction with pancreatic cells.
• Analysis of studies investigating ACE2 expression in pancreatic islets.
• Discussion of in vitro and in vivo evidence regarding SARS-CoV-2 infection of pancreatic cells.

Main Results:

• ACE2 is critical for regulating insulin sensitivity, secretion, and glucose metabolism in pancreatic beta cells.
• Evidence suggests SARS-CoV-2 can infect pancreatic cells, potentially via ACE2.
• Contradictory findings exist regarding ACE2 expression in pancreatic islets, necessitating further research.

Conclusions:

• ACE2 is a key factor in pancreatic beta cell function and may serve as an entry point for SARS-CoV-2.
• SARS-CoV-2 infection of the pancreas could directly contribute to diabetes pathogenesis.
• Further research into ACE2's role is vital for developing therapeutic strategies against COVID-19-related diabetes.